DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
BRKR logo

Bruker Corporation Stock Price

NasdaqGS:BRKR Community·US$8.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 34 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

BRKR Share Price Performance

US$53.43
21.36 (66.60%)
​
US$59.75
Fair Value
US$53.43
21.36 (66.60%)
10.6% undervalued intrinsic discount
US$59.75
Fair Value
Price US$53.43
AnalystConsensusTarget US$59.75
AnalystLowTarget US$42.30
AnalystHighTarget US$63.51
Fri, 24 Jul 26
Fair ValueUS$59.75
Share Pricen/a

BRKR Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$59.75 10.6% undervalued intrinsic discount

BRKR: Recent Upgrade Will Drive Confidence In Core Market Resilience

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$42.3 26.3% overvalued intrinsic discount

Falling Funding Will Depress Revenues But Cost Cuts Help Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$63.51 15.9% undervalued intrinsic discount

Growing Global Health R&D Investment Will Boost Diagnostic Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
BRKR logo
Bruker
10.6% undervalued intrinsic discount

BRKR: Recent Upgrade Will Drive Confidence In Core Market Resilience

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 24 Jul
Read Narrative
BRKR logo
Bruker
26.3% overvalued intrinsic discount

Falling Funding Will Depress Revenues But Cost Cuts Help Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 7 Aug
Read Narrative
BRKR logo
Bruker
15.9% undervalued intrinsic discount

Growing Global Health R&D Investment Will Boost Diagnostic Demand

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 7 May 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
BRKR logo

BRKR: Premium Multiple Will Face Earnings Risk After Recent Guidance Miss

Fair Value: US$42.3 26.3% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
BRKR logo

BRKR: Infection Detection Expansion Will Meet Rich Tools Sector Expectations

Fair Value: US$59.75 10.6% undervalued intrinsic discount
17 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
BRKR logo

Growing Global Health R&D Investment Will Boost Diagnostic Demand

Fair Value: US$63.51 15.9% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

1 Risk
3 Rewards
View Full Analysis

Bruker Corporation Key Details

US$3.5b

Revenue

US$1.8b

Cost of Revenue

US$1.7b

Gross Profit

US$1.8b

Other Expenses

-US$106.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.70
48.48%
-3.05%
75.4%
View Full Analysis

About BRKR

Founded
1960
Employees
11085
CEO
Frank Laukien
WebsiteView website
www.bruker.com

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Recent BRKR News & Updates

Recent updates

No updates

Bruker Corporation Competitors

MRNA logo

Moderna

Symbol: NasdaqGS:MRNA
Market cap: US$57.5b
NTRA logo

Natera

Symbol: NasdaqGS:NTRA
Market cap: US$47.4b
RVMD logo

Revolution Medicines

Symbol: NasdaqGS:RVMD
Market cap: US$43.7b
TEVA logo

Teva Pharmaceutical Industries

Symbol: NYSE:TEVA
Market cap: US$43.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide